Alert: Major Price Decline (7/30/24)-Novavax Inc (NASDAQ: NVAX).

out_logo_500#25196.jpg

On 7/30/24, Novavax Inc (NASDAQ: NVAX) stock suffered a major decline of -25.7%, closing at $12.20. Moreover, unusually high trading volume at 177% of normal accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -18.3% during the last week.

out_mm#25196.jpg

Current PriceTarget Research Rating

NVAX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a major Value Eraser.

Novavax is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*